5-(p-chlorophenoxy)picolinic acid | 72133-24-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 5-(p-chlorophenoxy)picolinic acid
• 英文别名: Picolinic acid, 5-(p-chlorophenoxy)-；5-(4-chlorophenoxy)pyridine-2-carboxylic acid
• CAS: 72133-24-5
• 化学式: C₁₂H₈ClNO₃
• 分子量: 249.653
• InChiKey: RXHAQWAUXWKINY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.4
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS<br/>[FR] COMPOSÉS DE TRIAZOLE ET D'IMIDAZOLE SUBSTITUÉS
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014086663A1

  公开（公告）日：2014-06-12

  The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are LMP7 inhibitors and may be useful in treating associated inflammatory diseases and disorders such as, for example, rheumatoid arthritis, lupus and irritable bowel disease.

  这项发明涉及式(I)的化合物及其药用可接受的盐。此外，本发明涉及制造和使用式(I)的化合物的方法，以及含有这种化合物的药物组合物。式(I)的化合物是LMP7抑制剂，可能在治疗相关的炎症性疾病和紊乱方面有用，例如类风湿性关节炎、红斑狼疮和肠易激综合征。
• SUBSTITUTED TRIAZOLE AND IMIDAZOLE COMPOUNDS
  申请人：HOFFMANN-LA ROCHE INC.

  公开号：US20150299143A1

  公开（公告）日：2015-10-22

  The invention is concerned with the compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are LMP7 inhibitors and may be useful in treating associated inflammatory diseases and disorders such as, for example, rheumatoid arthritis, lupus and irritable bowel disease.

  这项发明涉及公式（I）的化合物及其药学上可接受的盐。此外，本发明还涉及制造和使用公式（I）化合物的方法，以及包含这种化合物的药物组合物。公式（I）化合物是LMP7抑制剂，可能在治疗相关的炎症性疾病和紊乱方面有用，例如类风湿性关节炎，狼疮和肠易激综合症。
• Tocopheryl ester of 5-substituted picolinic acid, process for its production, and pharmaceutical composition containing it
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP0066242A1

  公开（公告）日：1982-12-08

  An a-tocopheryl 5-substituted picolinate of the formula wherein R represents an alkyl group which may have a substituent, a lower alkenyl group, a phenyl(lower alkyl) group, or a phenyl group which may have a substituent, and Q represents a methylene group or an oxygen or sulfur atom, or a pharmaceutically acceptable acid addition salt thereof. This compound can be produced by reacting a substituted picolinic acid of the formula wherein R and Q are as defined above, or its reactive derivative with a-tocopherol of the formula and as required, contacting the resulting compound with a pharmaceutically acceptable acid. A pharmaceutical composition comprising said compound as an active ingredient is useful for the treatment of hypertension.

  一种 a-生育酚 5-取代型吡啶甲酸盐，其式如下 其中 R 代表可能具有取代基的烷基、低级烯基、苯基（低级烷基）或可能具有取代基的苯基，Q 代表亚甲基或氧原子或硫原子，或其药学上可接受的酸加成盐。该化合物可通过反应式如下的取代的吡啶甲酸制得 式中 R 和 Q 如上定义，或其反应衍生物与式中 a-生育酚反应制得。 并根据需要将所得化合物与药学上可接受的酸接触。包含上述化合物作为活性成分的药物组合物可用于治疗高血压。
• US4229448A
  申请人：——

  公开号：US4229448A

  公开（公告）日：1980-10-21
• US4443459A
  申请人：——

  公开号：US4443459A

  公开（公告）日：1984-04-17